SCHEMBL30528375

SCHEMBL30528375

Cc1ccc2oc([Si](C)(C)C)cc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.41
KDM4E B2RXH2 8/20 0.41
NPC1 O15118 7/20 0.41
RAB9A P51151 7/20 0.41
ALDH1A1 P00352 6/20 0.41
HPGD P15428 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HSD17B10 Q99714 3/20 0.41
TP53 P04637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 5/20 0.39
CASP3 P42574 3/20 0.39
SENP7 Q9BQF6 3/20 0.39
SENP6 Q9GZR1 3/20 0.39
POLB P06746 2/20 0.39
SENP8 Q96LD8 2/20 0.39
LMNA P02545 3/20 0.37
CASP6 P55212 1/20 0.37
NFKB1 P19838 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1165531 1.00 CYP1A2 (0.41) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL7916567 0.79 CYP1A2 (0.48) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL17226532 0.78 MAPT (0.42) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL12317671 0.74 KDM4E (0.41) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL13908870 0.74 MAPT (0.40) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL20417229 0.74 CCR1 (0.38) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL17226510 0.73 GAA (0.49) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL24776541 0.72 L3MBTL1 (0.40) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL8041985 0.72 CYP2A6 (0.46) CYP1A2KDM4ENPC1RAB9AALDH1A1
SCHEMBL17429954 0.71 MEN1 (0.42) CYP1A2KDM4ENPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116600803-A Macrocyclic urea orexin receptor agonists 默沙东有限责任公司 2023-08-15 CN disclosed